Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Broadcom
AVGO
|
+$1.43B |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$805M |
| 3 |
Meta Platforms (Facebook)
META
|
+$713M |
| 4 |
Amazon
AMZN
|
+$688M |
| 5 |
Tesla
TSLA
|
+$525M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.96B |
| 2 |
Spotify
SPOT
|
+$1.22B |
| 3 |
Microsoft
MSFT
|
+$847M |
| 4 |
Apollo Global Management
APO
|
+$757M |
| 5 |
Workday
WDAY
|
+$444M |
Sector Composition
| 1 | Technology | 15.78% |
| 2 | Financials | 14.57% |
| 3 | Healthcare | 12.51% |
| 4 | Industrials | 10.47% |
| 5 | Consumer Discretionary | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVX
2701
NOVONIX
NVX
$201M
| $1.15M | ﹤0.01% |
639,083
-22,530
| -3% | -$40.6K |
|
2702
Progress Software
PRGS
$1.81B
| $1.15M | ﹤0.01% |
17,646
+5,534
| +46% | +$361K |
|
2703
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.4B
| $1.15M | ﹤0.01% |
22,203
-26,436
| -54% | -$1.37M |
|
2704
Enliven Therapeutics
ELVN
$1.18B
| $1.14M | ﹤0.01% |
50,804
+26,449
| +109% | +$595K |
|
|
LOGC
2705
DELISTED
ContextLogic
LOGC
| $1.14M | ﹤0.01% |
162,584
+1,056
| +0.7% | +$7.42K |
|
2706
Cheesecake Factory
CAKE
$2.82B
| $1.14M | ﹤0.01% |
24,082
-1,804,671
| -99% | -$85.6M |
|
2707
Mersana Therapeutics
MRSN
$35.6M
| $1.14M | ﹤0.01% |
31,839
+21,448
| +206% | +$767K |
|
2708
Applied Therapeutics
APLT
$60.6M
| $1.14M | ﹤0.01% |
1,329,149
+1,051,779
| +379% | +$901K |
|
|
UROY
2709
Uranium Royalty Corp
UROY
$420M
| $1.14M | ﹤0.01% |
518,784
+504,813
| +3,613% | +$1.11M |
|
2710
Core Laboratories
CLB
$581M
| $1.14M | ﹤0.01% |
65,616
+53,213
| +429% | +$921K |
|
2711
Nature's Sunshine
NATR
$299M
| $1.14M | ﹤0.01% |
+77,443
| New | +$1.14M |
|
2712
Horizon Bancorp
HBNC
$833M
| $1.13M | ﹤0.01% |
70,420
+19,828
| +39% | +$319K |
|
2713
Fresh Del Monte Produce
FDP
$1.71B
| $1.13M | ﹤0.01% |
34,140
-221,878
| -87% | -$7.37M |
|
2714
Telefonica
TEF
$30.3B
| $1.13M | ﹤0.01% |
281,932
+180,945
| +179% | +$727K |
|
2715
FS KKR Capital
FSK
$4.91B
| $1.13M | ﹤0.01% |
52,042
+8,279
| +19% | +$180K |
|
2716
Rentokil
RTO
$12.8B
| $1.12M | ﹤0.01% |
44,362
-27,408
| -38% | -$694K |
|
2717
Arbutus Biopharma
ABUS
$855M
| $1.12M | ﹤0.01% |
343,028
+92,068
| +37% | +$301K |
|
2718
Yum! Brands
YUM
$41.5B
| $1.12M | ﹤0.01% |
8,359
-113,072
| -93% | -$15.2M |
|
2719
iShares MSCI United Kingdom ETF
EWU
$2.93B
| $1.12M | ﹤0.01% |
33,046
+8,824
| +36% | +$299K |
|
2720
Shoals Technologies Group
SHLS
$1.15B
| $1.12M | ﹤0.01% |
201,812
-2,176,645
| -92% | -$12M |
|
2721
Dominion Energy
D
$51.2B
| $1.11M | ﹤0.01% |
20,686
-58,475
| -74% | -$3.15M |
|
2722
Immatics
IMTX
$707M
| $1.11M | ﹤0.01% |
+156,686
| New | +$1.11M |
|
2723
Bar Harbor Bankshares
BHB
$540M
| $1.11M | ﹤0.01% |
36,146
+28,774
| +390% | +$880K |
|
|
ZBIO
2724
Zenas BioPharma, Inc. Common Stock
ZBIO
$852M
| $1.1M | ﹤0.01% |
134,896
+17,515
| +15% | +$143K |
|
2725
USCB Financial Holdings
USCB
$349M
| $1.1M | ﹤0.01% |
62,133
+23,072
| +59% | +$410K |
|